ArticleInternational journal of molecular sciences2024
NAD
Krish Chandrasekaran, Neda Najimi, Avinash R Sagi, Sushuma Yarlagadda, Mohammad Salimian, Muhammed Ikbal Arvas, Ahmad F Hedayat, Yanni Kevas, Anand Kadakia, Tibor Kristian and 1 more
Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 4 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 1 institution in 1 country.
Krish ChandrasekaranDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Neda NajimiDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Avinash R SagiDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Sushuma YarlagaddaDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0001-6489-3854
Mohammad SalimianDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Muhammed Ikbal ArvasDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Ahmad F HedayatDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Yanni KevasDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Anand KadakiaDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
Tibor KristianDepartment of Anesthesiology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0002-1804-8999
James W RussellDepartment of Neurology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.ORCID 0000-0002-8940-8920
University of Maryland, Baltimore · US
Funding
Research BaseP30DK072488 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI MITCHELL, BRAXTON D, TAYLOR, SIMEON I. · 2005 to 2019
$17.3M
NAD+ and SIRT1 Regulate Mitochondrial Function in Diabetic NeuropathyR01DK107007 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI RUSSELL, JAMES W · 2016 to 2021
$2.3M
Using NAD+ precursor for treatment of global cerebral ischemiaR01NS119275 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI KRISTIAN, TIBOR · 2021 to 2025
$1.9M
The role of nicotinamide mononucleotide dependent mitochondrial reactive oxygen species generation in acute brain injuryI01BX004895 · VA · BALTIMORE VA MEDICAL CENTER · PI KRISTIAN, TIBOR · 2020 to 2024
–
Improving Autonomic Function and Balance in Diabetic NeuropathyI01RX001030 · VA · BALTIMORE VA MEDICAL CENTER · PI RUSSELL, JAMES W · 2015 to 2017
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.